heptelidic acid has been researched along with Benign Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baccile, JA; Baldi, R; Chio, IIC; Dai, Z; Elemento, O; Gao, X; Johnson, MO; Liberti, MV; Liu, X; Locasale, JW; Madhukar, NS; McDonnell, DP; Mehrmohamadi, M; Rathmell, JC; Schroeder, FC; Shestov, AA; Wardell, SE | 1 |
Hasumi, K; Kumagai, S; Narasaki, R | 1 |
2 other study(ies) available for heptelidic acid and Benign Neoplasms
Article | Year |
---|---|
A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product.
Topics: Animals; Cell Line, Tumor; Enzyme Inhibitors; Glucose; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycolysis; Humans; Machine Learning; Metabolic Flux Analysis; Metabolomics; Mice, Inbred C57BL; Models, Biological; Molecular Targeted Therapy; Neoplasms; Sesquiterpenes; Systems Biology | 2017 |
Glucose-dependent active ATP depletion by koningic acid kills high-glycolytic cells.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Glucose; Glycolysis; Humans; Mice; Neoplasms; Sesquiterpenes | 2008 |